These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hippocampal Aβ expression, but not phosphorylated tau, predicts cognitive deficits following repeated peripheral poly I:C administration. White JD; Eimerbrink MJ; Hayes HB; Hardy A; Van Enkevort EA; Peterman JL; Chumley MJ; Boehm GW Behav Brain Res; 2016 Oct; 313():219-225. PubMed ID: 27449203 [TBL] [Abstract][Full Text] [Related]
4. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline. Clausen A; Xu X; Bi X; Baudry M J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441 [TBL] [Abstract][Full Text] [Related]
5. Icariin attenuates β-amyloid-induced neurotoxicity by inhibition of tau protein hyperphosphorylation in PC12 cells. Zeng KW; Ko H; Yang HO; Wang XM Neuropharmacology; 2010 Nov; 59(6):542-50. PubMed ID: 20708632 [TBL] [Abstract][Full Text] [Related]
6. STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer's beta-amyloid deposits. Cancino GI; Toledo EM; Leal NR; Hernandez DE; Yévenes LF; Inestrosa NC; Alvarez AR Brain; 2008 Sep; 131(Pt 9):2425-42. PubMed ID: 18559370 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological modulation of GSAP reduces amyloid-β levels and tau phosphorylation in a mouse model of Alzheimer's disease with plaques and tangles. Chu J; Lauretti E; Craige CP; Praticò D J Alzheimers Dis; 2014; 41(3):729-37. PubMed ID: 24662099 [TBL] [Abstract][Full Text] [Related]
8. Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse. Ontiveros-Torres MÁ; Labra-Barrios ML; Díaz-Cintra S; Aguilar-Vázquez AR; Moreno-Campuzano S; Flores-Rodríguez P; Luna-Herrera C; Mena R; Perry G; Florán-Garduño B; Luna-Muñoz J; Luna-Arias JP J Alzheimers Dis; 2016 Mar; 52(1):243-69. PubMed ID: 27031470 [TBL] [Abstract][Full Text] [Related]
9. Fuzhisan Ameliorates the Memory Deficits in Aged SAMP8 Mice via Decreasing Aβ Production and Tau Hyperphosphorylation of the Hippocampus. Zhang ZX; Zhao RP; Wang DS; Li YB Neurochem Res; 2016 Nov; 41(11):3074-3082. PubMed ID: 27518086 [TBL] [Abstract][Full Text] [Related]
10. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease. Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371 [TBL] [Abstract][Full Text] [Related]
11. Tau passive immunization inhibits not only tau but also Aβ pathology. Dai CL; Tung YC; Liu F; Gong CX; Iqbal K Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379 [TBL] [Abstract][Full Text] [Related]
12. Immunolesion-induced loss of cholinergic projection neurones promotes β-amyloidosis and tau hyperphosphorylation in the hippocampus of triple-transgenic mice. Härtig W; Saul A; Kacza J; Grosche J; Goldhammer S; Michalski D; Wirths O Neuropathol Appl Neurobiol; 2014 Feb; 40(2):106-20. PubMed ID: 23566195 [TBL] [Abstract][Full Text] [Related]
13. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β. Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736 [TBL] [Abstract][Full Text] [Related]
14. Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus. Ali T; Kim MO J Pineal Res; 2015 Aug; 59(1):47-59. PubMed ID: 25858697 [TBL] [Abstract][Full Text] [Related]
15. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation. Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737 [TBL] [Abstract][Full Text] [Related]
16. Interplay between age, cerebral small vessel disease, parenchymal amyloid-β, and tau pathology: longitudinal studies in hypertensive stroke-prone rats. Schreiber S; Drukarch B; Garz C; Niklass S; Stanaszek L; Kropf S; Bueche C; Held F; Vielhaber S; Attems J; Reymann KG; Heinze HJ; Carare RO; Wilhelmus MM J Alzheimers Dis; 2014; 42 Suppl 3():S205-15. PubMed ID: 24825568 [TBL] [Abstract][Full Text] [Related]
17. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice. Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708 [TBL] [Abstract][Full Text] [Related]
18. Deficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer's disease. Li SQ; Yu Y; Han JZ; Wang D; Liu J; Qian F; Fan GH; Bucala R; Ye RD J Neuroinflammation; 2015 Sep; 12():177. PubMed ID: 26382037 [TBL] [Abstract][Full Text] [Related]
20. Gavage of D-Ribose induces Aβ-like deposits, Tau hyperphosphorylation as well as memory loss and anxiety-like behavior in mice. Wu B; Wei Y; Wang Y; Su T; Zhou L; Liu Y; He R Oncotarget; 2015 Oct; 6(33):34128-42. PubMed ID: 26452037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]